Patel: Lecture, educational and advisory related honoraria from AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Napp Pharmaceuticals, Novo Nordisk, Sanofi, MSD and Takeda
Key Points Tirzepatide (Mounjaro/Zepbound) works differently than semaglutide (Ozempic/Wegovy) by targeting two hormones instead of one Studies show tirzepatide typically leads to greater weight loss (15-20% vs 8-10%) and better blood sugar control than semaglutide Switching is generally straightforward you can finish your semaglutide dose and start tirzepatide about a week later on your normal dose day Most people start at a lower tirzepatide dose (2.5mg or 5mg) even if they were on a high dose of semaglutide Thinking about making the switch from semaglutide (Ozempic or Wegovy) to tirzepatide (Mounjaro or Zepbound)
It is used to treat anxiety in adults and major depressive disorder in adults and adolescents who are at least 12 years old
When properly used in laboratory-controlled settings, there will be safe handling and dependable experimental results
This method has gained popularity due to its higher bioavailability compared to traditional oral supplements